Immunogenetic control of brain tumor growth in rats
- PMID: 889589
Immunogenetic control of brain tumor growth in rats
Abstract
The susceptibility to intracerebral and s.c. growth of a transplantable gliosarcoma in genetically inbred rats correlated with histocompatibility type. The genetic control of tumor growth was tested in a cross between a tumor-susceptible strain (F344, Ag-B1) and a tumor-resistant strain (YO, Ag-B2). Susceptibility was transmitted as a dominant trait, and at least two genes or gene complexes were involved: one was linked to the major histocompatibility complex and one segregated independently of it. The genetic mechanisms did not appear to be affected significantly by the site (environment) in which the tumor grew. Antibodies to Ag-B1 histocompatibility antigens, which were those of the strain in which the tumor originated (F344), and to tumor-associated antigens were generally present in animals in which the tumor had regressed. Only tumor-specific antibodies appeared in the sera of Ag-B1 animals that had the tumor. A cytotoxic lymphokine was present in the sera of tumor-bearing animals, but its level did not correlate with tumor growth or regression.
Similar articles
-
Immunogenetic and immunologic aspects of gliosarcoma growth in rats.Lab Invest. 1983 Oct;49(4):436-44. Lab Invest. 1983. PMID: 6604839
-
Immunogenetic control of the immune response to gliosarcoma 9L growth in rats.Transplant Proc. 1981 Jun;13(2):1407-9. Transplant Proc. 1981. PMID: 7245333 No abstract available.
-
[Immunologic sensitization to tumor-associated antigens during the growth of gliomas of the brain (experimental study)].Zh Vopr Neirokhir Im N N Burdenko. 1984 Mar-Apr;(2):9-13. Zh Vopr Neirokhir Im N N Burdenko. 1984. PMID: 6741378 Russian.
-
Generation of cytotoxic immune responses against a rat glioma by in vivo priming and secondary in vitro stimulation with tumor cells.Neurosurgery. 1992 Apr;30(4):499-504; discussion 504-5. doi: 10.1227/00006123-199204000-00005. Neurosurgery. 1992. PMID: 1584347
-
Studies in histocompatibility.Science. 1981 Jul 10;213(4504):172-8. doi: 10.1126/science.7017931. Science. 1981. PMID: 7017931 Review. No abstract available.
Cited by
-
Analysis of interleukin 2 and various effector cell populations in adoptive immunotherapy of 9L rat gliosarcoma: allogeneic cytotoxic T lymphocytes prevent tumor take.Proc Natl Acad Sci U S A. 1990 Dec;87(24):9577-81. doi: 10.1073/pnas.87.24.9577. Proc Natl Acad Sci U S A. 1990. PMID: 2263613 Free PMC article.
-
Allogeneic tumor-specific cytotoxic T lymphocytes.Cancer Immunol Immunother. 1992;34(5):349-54. doi: 10.1007/BF01741557. Cancer Immunol Immunother. 1992. PMID: 1371720 Free PMC article.
-
The immunological response of Wistar rats to the intracranially implanted C-6 glioma cell line.J Neurooncol. 1983;1(4):365-72. doi: 10.1007/BF00165720. J Neurooncol. 1983. PMID: 6678975
-
Immunogenetic aspects of intracerebral skin transplantation in inbred rats.Am J Pathol. 1979 Mar;94(3):569-84. Am J Pathol. 1979. PMID: 371412 Free PMC article.
-
Rejection of RG-2 gliomas is mediated by microglia and T lymphocytes.J Neurooncol. 2006 Sep;79(3):243-53. doi: 10.1007/s11060-006-9137-x. Epub 2006 Apr 13. J Neurooncol. 2006. PMID: 16612573
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources